Institute of Biomedicine of Seville (IBiS), Hospital University "Virgen del Rocío"/CSIC/University of Seville, Seville, Spain.
Center for Natural and Human Sciences, Federal University of ABC, Santo André, SP, Brazil.
Int J Nanomedicine. 2024 Nov 23;19:12409-12420. doi: 10.2147/IJN.S474643. eCollection 2024.
Hepatocellular carcinoma (HCC) is the main hepatic primary malignancy. Patients with advanced HCC receiving the recommended therapies have a poor outcome. In different settings, nanotechnology has gained attraction as a potential alternative strategy for improving therapeutic effectiveness. Among several nanoparticles (NPs), inorganic NPs, such as zinc and silicon oxides (ZnO and SiO), are mainly chosen as drug nanocarriers, as both present great adsorption properties and biocompatibility.
The objective is to identify the molecular mechanisms underlying the proapoptotic effects of ZnO and SiO NPs in differentiated hepatoblastoma cells (HepG2) and mesenchymal liver cancer cells (SNU449).
Dose-dependent induction of cell cytotoxicity by ZnO and SiO NPs (5 to 50 µg/mL) was determined in HepG2 and SNU449 cells. NPs intracellular localization was assessed using transmission electron microscopy (TEM). Cell death was determined by trypan blue staining and caspase-3 and -8 activities. Cell respiration was determined using MitroStress assay (Seahorse, Agilent).
ZnO NPs, but not SiO NPs, reduced cell viability in HepG2 and SNU449. Interestingly, SNU449 appeared to be more susceptible than HepG2 to ZnO NPs (IC50 of 27.4 ± 1.4 µg/mL and 41.8 ± 0.4 µg/mL, respectively). SiO NPs tended to be localized in lysosomes in both cell lines, while ZnO NPs demonstrated a random distribution with a high presence in mitochondria and related structures. As expected, SiO NPs did not reduce cell survival and cell respiration, while ZnO NPs promoted cell death and decreased oxygen consumption rate. ZnO NPs mitochondrial accumulation was associated with increased apoptosis in HepG2, while necroapoptosis was mainly involved in ZnO-induced cell death in SNU449.
SiO demonstrated no cytotoxic profile against liver cancer cells. ZnO NPs demonstrated to accumulate in mitochondria impacting cell respiration and cell death in liver cancer cells. ZnO induced apoptosis and necroptosis in HepG2 and SNU449, respectively.
肝细胞癌(HCC)是主要的肝原发性恶性肿瘤。接受推荐疗法的晚期 HCC 患者预后不良。在不同的环境中,纳米技术作为提高治疗效果的潜在替代策略引起了关注。在几种纳米颗粒(NPs)中,无机 NPs,如氧化锌和氧化硅(ZnO 和 SiO),主要被选择作为药物纳米载体,因为它们都具有很好的吸附性能和生物相容性。
本研究旨在确定 ZnO 和 SiO NPs 在分化的肝癌细胞(HepG2)和间质肝癌细胞(SNU449)中促凋亡作用的分子机制。
在 HepG2 和 SNU449 细胞中,用 ZnO 和 SiO NPs(5 至 50μg/mL)测定细胞毒性的剂量依赖性诱导。用透射电子显微镜(TEM)评估 NPs 的细胞内定位。用台盼蓝染色和 caspase-3 和 -8 活性测定细胞死亡。用 MitroStress 测定法(海瑟尔,安捷伦)测定细胞呼吸。
ZnO NPs 降低了 HepG2 和 SNU449 细胞的活力,但 SiO NPs 没有。有趣的是,SNU449 似乎比 HepG2 对 ZnO NPs 更敏感(IC50 分别为 27.4±1.4μg/mL 和 41.8±0.4μg/mL)。SiO NPs 倾向于在两种细胞系中定位于溶酶体,而 ZnO NPs 则呈随机分布,高浓度存在于线粒体及其相关结构中。正如预期的那样,SiO NPs 不会降低细胞存活率和细胞呼吸率,而 ZnO NPs 则促进细胞死亡和降低耗氧率。ZnO NPs 的线粒体积累与 HepG2 中的细胞凋亡增加有关,而 SNU449 中的细胞死亡主要涉及坏死凋亡。
SiO 对肝癌细胞没有显示出细胞毒性。ZnO NPs 被证明在线粒体中积累,影响肝癌细胞的细胞呼吸和细胞死亡。ZnO 在 HepG2 和 SNU449 中分别诱导凋亡和坏死凋亡。